Brilliant Violet 421™ anti-human CD25 Antibo
- 产品名称：
- Brilliant Violet 421™ anti-human CD25 Antibo
- 产品类别：
- 抗体
- 产品编号：
- 302629
- 产品应用：
- 302629
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 2220 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- Baboon, Chimpanzee, Cynomolgus, Pigtailed Macaque, Rhesus
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.
Learn more about Brilliant Violet?.
This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents. - Excitation Laser
- Violet Laser (405 nm)
- Application Notes
Additional reported applications include: immunocytochemistry3.
- Additional Product Notes
View more applications data for this product in our Scientific Poster Library.
- Application References
(PubMed link indicates BioLegend citation) -
- Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
- Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
- Ernst CW, et al. 2007. Clin. Exp. Immunol. 148:271. (ICC) PubMed
- Product Citations
-
- Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
- Shoda H, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1308-y. PubMed
- Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed
- van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
- Nesspor TC, et al. 2020. Sci Rep. 10:7557. PubMed
- Huang C, et al. 2020. Theranostics. 10:10498. PubMed
- Pan YG, et al. 2021. Immunity. 54(6):1245-1256.e5. PubMed
- Torres-Ruiz J, et al. 2021. Front Immunol. 12:689966. PubMed
- Herter JM, et al. 2022. Strahlenther Onkol. Online ahead of print. PubMed
- Lam AJ, et al. 2021. Cell Reports. 36(5):109494. PubMed
- Pagel J, et al. 2020. Front Immunol. 11:565257. PubMed
- Jürchott K, et al. 2016. PLoS One. 11: 0150812. PubMed
- Yang L, et al. 2020. Genes Dis. 7:128. PubMed
- Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
- Idorn M, et al. 2018. Oncoimmunology. 7:e1412029. PubMed
- Nowak A, et al. 2018. Front Immunol. 0.513194444. PubMed
- Gao X, et al. 2022. iScience. 25:104911. PubMed
- Nguyen J, et al. 2021. Mol Syst Biol. 17:e10560. PubMed
- Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
- Nakachi S, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1309-x. PubMed
- Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
- Hernndez DC, et al. 2021. Immunity. :. PubMed
- Pandya J, et al. 2016. J Leukoc Biol. 100: 823 - 833. PubMed
- Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
- Li H, et al. 2020. Front Oncol. 1.477083333. PubMed
- Nowatzky J, et al. 2020. J Vis Exp. . PubMed
- Fu J, et al. 2021. J Clin Invest. 131:. PubMed
- Lin-Shiao E, et al. 2022. Nucleic Acids Res. 50:1256. PubMed
- RRID
- AB_10896914 (BioLegend Cat. No. 302629) AB_11126749 (BioLegend Cat. No. 302630)
- Structure
- Type I transmembrane glycoprotein, 55 kD
- Distribution
-
Activated T cells and B cells, monocytes/macrophages, Treg
- Function
- Associates with IL-2 receptor β (CD122) and γ chains (CD132) to form high affinity IL-2R complex
- Ligand/Receptor
- IL-2
- Cell Type
- B cells, Macrophages, Monocytes, T cells, Tregs
- Biology Area
- Cell Biology, Immunology, Neuroscience, Neuroscience Cell Markers
- Molecular Family
- CD Molecules, Cytokine/Chemokine Receptors
- Antigen References
-
1. Taniguchi T, et al. 1993. Cell 73:5.
2. Waldmann T. 1991. J. Biol. Chem. 266:2681.
- Gene ID
- 3559 View all products for this Gene ID
- UniProt
- View information about CD25 on UniProt.org
